Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

11/05/2020 | 07:03am EST

Item 2.02 Results of Operations and Financial Condition

On November 5, 2020, Sage Therapeutics, Inc. announced its financial results for the quarter ended September 30, 2020. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
  No.       Description

99.1          Press release issued by Sage Therapeutics, Inc. on November 5, 2020,
            furnished herewith.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about SAGE THERAPEUTICS, INC.
01/22SAGE THERAPEUTICS : BMO Capital Downgrades Sage Therapeutics to Market Perform F..
MT
01/22PRESS RELEASE : BB BIOTECH AG: Vaccines leading -2-
DJ
01/19SAGE THERAPEUTICS : Wedbush Adjusts Price Target on Sage Therapeutics to $98 Fro..
MT
01/07SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other E..
AQ
01/07SAGE THERAPEUTICS : Provides 2021 Corporate Strategy Update at J.P. Morgan Healt..
BU
01/04SAGE THERAPEUTICS : Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, S..
MT
01/04SAGE THERAPEUTICS : RBC Downgrades Sage Therapeutics to Sector Perform From Outp..
MT
2020SAGE THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
2020SAGE THERAPEUTICS : to Present at the 39th Annual J.P. Morgan Healthcare Confere..
BU
2020SAGE THERAPEUTICS : Names Barry Greene CEO
MT
More news